查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532834

免疫療法藥物市場，按類型、按產品、按分佈、按給藥途徑、最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Immunotherapy Drugs Market, By Type, By Product, By Distribution, By Route of Administration, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 381 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年免疫治療藥物市場規模為2,788.9778億美元，2024年至2032年複合年成長率為14.92%。

免疫治療藥物市場-市場動態

全球癌症病例數不斷增加

癌症發生率的不斷上升推動了對有效治療的需求。免疫療法利用人體的免疫系統來對抗癌症，正在成為一種流行的選擇，導致這些藥物的市場不斷擴大。對新的、更有效的治療方法的需求刺激了研發 (R&D) 的投資。這包括資助臨床試驗、探索新的免疫療法和開發新藥。公司正在擴大產品組合併進入新市場，以滿足不斷成長的需求。這包括開發針對不同類型癌症的療法以及創建增強免疫療法有效性的組合療法。例如，為了創造新穎的、潛在有效的癌症藥物，倫敦癌症研究所的研究人員正在與小分子免疫腫瘤學企業 NeoPhore 合作，以鑑定新抗原。作為新策略研究合作的一部分，Chris Lord 教授領導下的 ICR 團隊將在實驗室中研究 NeoPhore 抑制劑如何影響腫瘤。

免疫治療藥物市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 14.92% 左右的複合年成長率成長

根據類型細分，預計單株抗體將在 2023 年呈現最大市場佔有率

從產品細分來看，生物製劑是2023年的主導類型

從分銷細分來看，零售藥局是2023年的主導類型

根據最終用戶細分，醫院是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

免疫治療藥物市場-細分分析：

全球免疫療法藥物市場根據類型、產品、分銷、給藥途徑、最終用戶和地區進行細分。

根據產品類型，市場分為六類：單株抗體、疫苗、檢查點抑制劑、非特異性免疫療法、溶瘤病毒免疫療法和T細胞療法。 mAb 旨在特異性結合某些抗原，例如癌細胞、病原體或發炎細胞表面的蛋白質。這種標靶最大限度地減少對健康細胞和組織的損害，使治療更有效並減少副作用。它們提供高度特異性的治療，有助於準確診斷和治療疾病。

根據應用，市場分為五類：醫院、診所、癌症研究中心、門診手術中心和家庭護理機構。免疫療法藥物旨在增強或恢復人體自然免疫系統識別和破壞癌細胞的能力。與化療和放療等傳統治療方法相比，這種有針對性的方法更有效，對健康細胞的損害也更小。免疫療法可以根據癌症的特定特徵針對個別患者進行客製化。這種個人化的方法可以改善治療效果並減少副作用。

免疫療法藥物市場 - 地理洞察

免疫治療藥物市場是製藥業中一個快速成長的領域，北美地區的活動和發展都非常活躍。美國因其先進的醫療基礎設施、大量的研發投資和高癌症盛行率而成為免疫治療市場的主要參與者。 FDA 對多種免疫療法藥物的批准以及生物技術和製藥公司的強大影響力推動了成長。德國、法國和英國等國家因其強大的醫療保健系統和活躍的研究機構而在免疫治療市場中佔據主導地位。歐洲藥品管理局 (EMA) 在藥品核准和市場准入方面發揮著至關重要的作用。此外，在癌症發病率上升和醫療基礎設施改善的推動下，印度是一個新興市場，對免疫療法的興趣日益濃厚。 2023年10月，印度與美國食品藥物管理局對應的中央藥品標準控制組織使NexCAR19成為印度首個核准的CAR-T細胞療法。

免疫療法藥物市場-競爭格局：

免疫療法藥物市場的領導者包括百時美施貴寶、默克、羅氏、輝瑞、諾華和安進等。點抑制劑、 CAR-T 細胞療法和其他創新療法。默沙東是PD-1/PD-L1抑制劑的市場領導者，擁有豐富的臨床試驗資料和廣泛的適應症。輝瑞在免疫治療和標靶治療方面擁有專業知識，並且擁有強大的臨床研究。 2024 年 2 月，佛羅裡達大學健康癌症中心的研究人員團隊開發了一種首創的化合物，可以為使用免疫療法治療各種類型的癌症開闢一條新途徑。此外，加州THOUSAND OAKS 和新澤西州KENILWORTH 宣布開展一項癌症免疫治療合作，以支持一項1b/3 期研究，該研究調查BLINCYTO 聯合KEYTRUDA 治療瀰漫性大B 細胞淋巴瘤(DLBCL) 患者，DLBCL 是最常見的疾病非何杰金氏淋巴瘤（NHL）的類型。該市場的特點是快速創新，重點是開發新的、更有效的療法，包括聯合療法和個人化治療。

最新進展：

2024年4月，BostonGene和佐賀大學宣布啟動一項合作，旨在發現晚期非小細胞肺癌（NSCLC）患者免疫療法（IO）治療反應和治療相關毒性的生物標記。 EGFR-TKI 治療有效針對 EGFR 突變陽性 NSCLC。儘管如此，獲得性抗藥性通常會導致 1 至 2 年內復發，這對治療後最佳化提出了挑戰。

2022 年 6 月，馬剋癌症研究基金會擴大了與約翰霍普金斯大學的合作關係，以加速突破性的免疫療法研究。與 Bloomberg~Kimmel 研究所的合作使我們能夠開發用於拯救生命所需的癌症免疫治療的下一代基因組學和成像平台。

目錄

第1章：免疫治療藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的免疫治療藥物市場片段
    • 免疫治療藥物市場片段（按產品）
    • 免疫治療藥物市場片段（依分佈）
    • 按給藥途徑分類的免疫治療藥物市場片段
    • 最終用戶的免疫治療藥物市場片段
    • 按國家/地區分類的免疫治療藥物市場片段
    • 按地區分類的免疫療法藥物市場片段
  • 競爭洞察

第 3 章：免疫治療藥物主要市場趨勢

  • 免疫治療藥物市場促進因素
    • 市場促進因素的影響分析
  • 免疫治療藥物市場限制
    • 市場限制影響分析
  • 免疫治療藥物市場機會
  • 免疫療法藥物市場未來趨勢

第 4 章：免疫治療藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：免疫治療藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：免疫治療藥物市場格局

  • 2023 年免疫治療藥物市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：免疫治療藥物市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 單株抗體
    • 疫苗
    • 檢查點抑制劑
    • 非特異性免疫療法
    • 溶瘤病毒免疫療法
    • T細胞療法

第 8 章：免疫治療藥物市場 - 副產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 生物製劑
      • 重組蛋白
      • 抗體
    • 小分子

第 9 章：免疫治療藥物市場 - 按分佈

  • 概述
    • 按分佈分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 網路藥局

第 10 章：免疫治療藥物市場 - 按給藥途徑

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 靜脈注射 (IV)
    • 皮下
    • 口服
    • 肌肉注射

第 11 章：免疫治療藥物市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 癌症研究中心
    • 門診手術中心
    • 家庭護理設置

第 12 章：免疫治療藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美免疫療法藥物主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按分佈）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲免疫療法藥物主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按產品）
    • 歐洲市場規模與預測（按分佈）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區免疫治療藥物主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按產品）
    • 亞太地區市場規模與預測（按分佈）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲免疫療法藥物主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按產品）
    • 拉丁美洲市場規模與預測（按分佈）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲免疫療法藥物主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按分佈）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 13 章：主要供應商分析 - 免疫療法藥物產業

  • 競爭儀表板
  • 公司簡介
    • Bristol-Myers Squibb
    • Merck & Co.
    • Roche
    • Pfizer
    • Novartis
    • Gilead Sciences
    • Amgen
    • Sanofi
    • Regeneron Pharmaceuticals
    • Bluebird Bio
    • Cellectis
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3460

REPORT HIGHLIGHT

Immunotherapy Drugs Market size was valued at USD 278,897.78 million in 2023, expanding at a CAGR of 14.92% from 2024 to 2032.

The rising number of cancer cases worldwide is a major driver for the growth of immunotherapy drugs. Immunotherapies offer new hope for patients with various types of cancer. Continuous R&D in immunotherapy has led to the development of more effective and targeted therapies, including checkpoint inhibitors, CAR-T cell therapies, and monoclonal antibodies. However, some immunotherapies can cause severe side effects, such as cytokine release syndrome or autoimmune reactions, which need careful management. The production of some immunotherapy drugs, like CAR-T cell therapies, involves complex and costly manufacturing processes. Furthermore, strategic collaborations between pharmaceutical companies, research institutions, and biotech firms can accelerate the development of new therapies and expand market reach.

Immunotherapy Drugs Market- Market Dynamics

The increasing number of cancer cases worldwide

The growing incidence of cancer drives demand for effective treatments. Immunotherapy, which harnesses the body's immune system to fight cancer, is becoming a popular choice, leading to an increased market for these drugs. The need for new and more effective treatments spurs investment in research and development (R&D). This includes funding for clinical trials, exploring new immunotherapy approaches, and developing novel drugs. Companies are expanding their product portfolios and entering new markets to meet the growing demand. This includes developing therapies for different types of cancer and creating combination treatments that enhance the effectiveness of immunotherapies. For instance, To create novel, potentially effective cancer medications, researchers at The Institute of Cancer Research, London, are collaborating with NeoPhore, a small molecule immuno-oncology business, to identify neoantigens. An ICR team under the direction of Professor Chris Lord will examine how NeoPhore's inhibitors affect tumors in the lab as part of a new strategic research cooperation.

Immunotherapy Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.92% over the forecast period (2024-2032)

Based on type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on product segmentation, Biologics was the leading type in 2023

Based on distribution segmentation, Retail Pharmacies was the leading type in 2023

Based on end-user segmentation, Hospitals was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Immunotherapy Drugs Market- Segmentation Analysis:

The Global Immunotherapy Drugs Market is segmented based on Type, Product, Distribution, Route of Administration, End User, and Region.

The market is divided into six categories based on product type: Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Non-Specific Immunotherapies, Oncolytic Virus Immunotherapy, and T-Cell Therapy. mAbs are designed to bind specifically to certain antigens, such as proteins on the surface of cancer cells, pathogens, or inflammatory cells. This targeting minimizes damage to healthy cells and tissues, making treatments more effective and reducing side effects. They provide high specificity in treatment, which helps in accurately diagnosing and treating diseases.

The market is divided into five categories based on application: Hospitals, Clinics, Cancer Research Centers, Ambulatory Surgical Centers, and Homecare Settings. Immunotherapy drugs are designed to enhance or restore the body's natural immune system's ability to recognize and destroy cancer cells. This targeted approach can be more effective and less damaging to healthy cells compared to traditional treatments like chemotherapy and radiation. Immunotherapy can be tailored to individual patients based on the specific characteristics of their cancer. This personalized approach can improve treatment outcomes and reduce side effects.

Immunotherapy Drugs Market- Geographical Insights

The immunotherapy drugs market is a rapidly growing sector in the pharmaceutical industry, with significant activity and development occurring across North American regions. The U.S. is a major player in the immunotherapy market due to its advanced healthcare infrastructure, substantial R&D investments, and high prevalence of cancer. The FDA's approval of numerous immunotherapy drugs and the strong presence of biotech and pharmaceutical companies drive growth. Countries like Germany, France, and the UK are prominent in the immunotherapy market due to their strong healthcare systems and active research institutions. The European Medicines Agency (EMA) plays a crucial role in drug approvals and market access. Furthermore, India is an emerging market with growing interest in immunotherapy, driven by increasing cancer incidence and improving healthcare infrastructure. In October 2023, India's counterpart to the US Food and Drug Administration, the Central Drugs Standard Control Organization, made NexCAR19 India's first approved CAR-T cell therapy.

Immunotherapy Drugs Market- Competitive Landscape:

Leading players in the immunotherapy drugs market Bristol-Myers Squibb, Merck & Co., Roche, Pfizer, Novartis, and Amgen, etc. The immunotherapy drugs market is diverse and includes several key players across various segments, including monoclonal antibodies, checkpoint inhibitors, CAR-T cell therapies, and other innovative treatments. Merck & Co. is a market leader in PD-1/PD-L1 inhibitors, with extensive clinical trial data, and broad indications. Pfizer has expertise in both immunotherapy and targeted therapies and strong clinical research. In February 2024, A team of UF Health Cancer Center researchers developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of cancer. In addition, THOUSAND OAKS, Calif. and KENILWORTH, N.J., announced a cancer immunotherapy collaboration to support a Phase 1b/3 study investigating BLINCYTO in combination with KEYTRUDA in patients with diffuse large B-cell lymphoma (DLBCL), which is the most common type of non-Hodgkin lymphoma (NHL). The market is characterized by rapid innovation, with a focus on developing new and more effective therapies, including combination therapies and personalized treatments.

Recent Developments:

In April 2024, BostonGene and Saga University announced the launch of a collaboration aimed at discovering biomarkers for immunotherapy (IO) treatment response and treatment-related toxicity in advanced non-small cell lung cancer (NSCLC) patients. EGFR-TKI treatment effectively targets EGFR mutation-positive NSCLC. Still, acquired resistance often leads to recurrence within 1 to 2 years, presenting a challenge for post-treatment optimization.

In June 2022, The Mark Foundation for Cancer Research expanded its partnership with the Johns Hopkins University to accelerate groundbreaking immunotherapy research. The collaboration with the Bloomberg~Kimmel Institute allows us to develop the next-generation genomics and imaging platforms for cancer immunotherapy necessary to save lives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOTHERAPY DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bristol-Myers Squibb

Merck & Co.

Roche

Pfizer

Novartis

Gilead Sciences

Amgen

Sanofi

Regeneron Pharmaceuticals

Bluebird Bio

Cellectis

Others

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies
  • Vaccines
  • Checkpoint Inhibitors
  • Non-Specific Immunotherapies
  • Oncolytic Virus Immunotherapy
  • T-Cell Therapy

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Biologics
  • Recombinant Proteins
  • Antibodies
  • Small Molecules

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Intravenous (IV)
  • Subcutaneous
  • Oral
  • Intramuscular

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Cancer Research Centers
  • Ambulatory Surgical Centers
  • Homecare Settings

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunotherapy Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunotherapy Drugs Market Snippet by Type
    • 2.1.2. Immunotherapy Drugs Market Snippet by Product
    • 2.1.3. Immunotherapy Drugs Market Snippet by Distribution
    • 2.1.4. Immunotherapy Drugs Market Snippet by Route of Administration
    • 2.1.5. Immunotherapy Drugs Market Snippet by End User
    • 2.1.6. Immunotherapy Drugs Market Snippet by Country
    • 2.1.7. Immunotherapy Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunotherapy Drugs Key Market Trends

  • 3.1. Immunotherapy Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunotherapy Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunotherapy Drugs Market Opportunities
  • 3.4. Immunotherapy Drugs Market Future Trends

4. Immunotherapy Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunotherapy Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunotherapy Drugs Market Landscape

  • 6.1. Immunotherapy Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunotherapy Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Vaccines
    • 7.1.4. Checkpoint Inhibitors
    • 7.1.5. Non-Specific Immunotherapies
    • 7.1.6. Oncolytic Virus Immunotherapy
    • 7.1.7. T-Cell Therapy

8. Immunotherapy Drugs Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 8.1.2. Biologics
      • 8.1.2.1. Recombinant Proteins
      • 8.1.2.2. Antibodies
    • 8.1.3. Small Molecules

9. Immunotherapy Drugs Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies

10. Immunotherapy Drugs Market - By Route of Administration

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 10.1.2. Intravenous (IV)
    • 10.1.3. Subcutaneous
    • 10.1.4. Oral
    • 10.1.5. Intramuscular

11. Immunotherapy Drugs Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Clinics
    • 11.1.4. Cancer Research Centers
    • 11.1.5. Ambulatory Surgical Centers
    • 11.1.6. Homecare Settings

12. Immunotherapy Drugs Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Immunotherapy Drugs Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Immunotherapy Drugs Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Immunotherapy Drugs Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Immunotherapy Drugs Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Immunotherapy Drugs Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Immunotherapy Drugs Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Bristol-Myers Squibb
    • 13.2.2. Merck & Co.
    • 13.2.3. Roche
    • 13.2.4. Pfizer
    • 13.2.5. Novartis
    • 13.2.6. Gilead Sciences
    • 13.2.7. Amgen
    • 13.2.8. Sanofi
    • 13.2.9. Regeneron Pharmaceuticals
    • 13.2.10. Bluebird Bio
    • 13.2.11. Cellectis
    • 13.2.12. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immunotherapy Drugs Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Immunotherapy Drugs Market, by Type 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Immunotherapy Drugs Market, by Product 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Immunotherapy Drugs Market, by Distribution 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: Route of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Immunotherapy Drugs Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Immunotherapy Drugs Market, by End User 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immunotherapy Drugs Market, by Region 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Immunotherapy Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Product segment market share analysis, 2023 & 2032
  • FIGURE Product segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2023 & 2032
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE Europe Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE Asia Pacific Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE Latin America Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE Middle East and Africa Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Immunotherapy Drugs Market share analysis by country, 2023
  • FIGURE Germany Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Immunotherapy Drugs Market share analysis by country, 2023
  • FIGURE India Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Immunotherapy Drugs Market share analysis by country, 2023
  • FIGURE Brazil Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Immunotherapy Drugs Market share analysis by country, 2023
  • FIGURE Saudi Arabia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)